What is BioSked?
BioSked offers Momentum, an AI-driven scheduling software tailored for hospitals, clinics, and medical practices. This robust platform is utilized across various medical specialties, including radiology and emergency medicine, to automate physician schedules, meticulously track RVUs (Relative Value Units), and ensure adherence to compliance standards. Momentum is engineered to simplify the complex scheduling process, empowering healthcare organizations to develop equitable and efficient staff rosters while substantially reducing administrative overhead. With a user base exceeding 50,000 daily professionals across more than 1,000 healthcare facilities in 9 countries, BioSked is dedicated to enhancing staff morale and improving patient access to care.
How much funding has BioSked raised?
BioSked has raised a total of $123K across 1 funding round:
Private Equity
$123K
Private Equity (2025): $123K, investors not publicly disclosed
What's next for BioSked?
The substantial backing from its latest funding rounds positions BioSked for accelerated expansion and product development. As a company operating in the large-scale, late-stage funding environment, BioSked is likely focused on scaling its operations, enhancing its AI capabilities within the Momentum platform, and potentially exploring new market segments or geographical regions. The strategic investment suggests a focus on solidifying its market leadership and further optimizing healthcare operational efficiency through advanced technology.
See full BioSked company page
